Cited by 126Cardiovascular Health and Disease PreventionCardiovascular Health and Risk FactorsCardiovascular Function and Risk Factors

Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study

Open access
Niiranen, Teemu J., Lyass, Asya, Larson, Martin G., Hamburg, Naomi M., Benjamin, Emelia J., Mitchell, Gary F., Vasan, Ramachandran S.·2017·Hypertension

Abstract

Hypertension and increased vascular stiffness are viewed as inevitable parts of aging. To elucidate whether the age-related decrease in vascular function is avoidable, we assessed the prevalence, correlates, and prognosis of healthy vascular aging (HVA) in 3196 Framingham Study participants aged ≥50 years. We defined HVA as absence of hypertension and pulse wave velocity <7.6 m/s (mean+2 SD of a reference sample aged <30 years). Overall, 566 (17.7%) individuals had HVA, with prevalence decreasing from 30.3% in people aged 50 to 59 to 1% in those aged ≥70 years. In regression models adjusted for physical activity, caloric intake, and traditional cardiovascular disease (CVD) risk factors, we observed that lower age, female sex, lower body mass index, use of lipid-lowering drugs, and absence of diabetes mellitus were cross-sectionally associated with HVA ( P <0.001 for all). A unit increase in a cardiovascular health score (Life’s Simple 7) was associated with 1.55-fold (95% confidence interval, 1.38–1.74) age- and sex-adjusted odds of HVA. During a follow-up of 9.6 years, 391 CVD events occurred. In Cox regression models adjusted for traditional CVD risk factors, including blood pressure, HVA was associated with a hazard ratio of 0.45 (95% confidence interval, 0.26–0.77) for CVD relative to absence of HVA. Although HVA is achievable in individuals acculturated to a Western lifestyle, maintaining normal vascular function beyond 70 years of age is challenging. Although our data are observational, our findings support prevention strategies targeting modifiable factors and behaviors and obesity, in particular, to prevent or delay vascular aging and the associated risk of CVD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.117.09026

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 51 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Niiranen, T. J., Lyass, A., Larson, M. G., Hamburg, N. M., Benjamin, E. J., Mitchell, G. F., & Vasan, R. S.
Affiliations
Boston University (US)
Venue
Hypertension
Published
2017-08
Volume
70
Issue
2
Pages
267-274
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2763062395
Cited by
126
References
51
Citations by year
2026: 5 · 2025: 10 · 2024: 14 · 2023: 11 · 2022: 16 · 2021: 15 · 2020: 16 · 2019: 13 · 2018: 21 · 2017: 5
FWCI
11.62
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01hc25195-41-0-1)
  • National Heart, Lung, and Blood Institute (HHSN268201500001I, HHSN268201500001C, R01HL094898, N01-HC-025195, R01HL107385, R01HL070100, R01HL104184, R01HL126136, R01HL060040)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082447)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
pulse wave velocity, vascular stiffness, cardiovascular risk, Life's Essential 8, cardiovascular health, body mass index, diabetes mellitus, lipid-lowering drugs, obesity, Framingham Heart Study, community-dwelling older adults, cardiovascular disease prevention
MeSH terms
Adult, Age Factors, Aged, Hypolipidemic Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Life Style, Male, Middle Aged, Prognosis, Research Design, Risk Factors, Sex Factors, Statistics as Topic, Exercise, Body Mass Index, Prevalence, Risk Assessment, Vascular Stiffness, Pulse Wave Analysis, Protective Factors, Diet, Western

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review